Skip to main content
. 2007 Jun 4;104(24):10158–10163. doi: 10.1073/pnas.0703478104

Fig. 4.

Fig. 4.

Coexpression of CD44 and CD166 in human CRC xenografts. (A–D) Analysis of CD166 expression in human CRC xenografts revealed that CD166 was differentially expressed within cancer cell populations and that all analyzed tumors contained a distinct CD44+/CD166+ double-positive cell subset.